Our toxicology studies and IND-enabling programs are tailored to the type of molecule being developed, relevant regulatory guidance, and with the planned clinical treatment regimen in mind. We help our clients de-risk their molecules and understand FDA and EMA feedback related to the next stage of drug development.
FDA and ICH guidance documents and GLP regulations provide directive on the design and conduct of toxicology studies at our AALAC accredited animal facility. Our board-certified veterinary pathologists put their findings in context of overall health and our historical control database. Clients come to Southern Research for a customer-focused experience where knowledge and quality meet operational excellence.